Stocktoria
Aclaris Therapeutics, Inc. ACRS
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2015-10-07
Aclaris Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| CITADEL ADVISORS LLC | 2,818,019 | $10.6M |
| D. E. Shaw & Co., Inc. | 900,804 | $3.4M |
| MILLENNIUM MANAGEMENT LLC | 756,127 | $2.8M |
| BlackRock Finance, Inc. | 2,032,155 | $2.2M |
| RENAISSANCE TECHNOLOGIES LLC | 502,631 | $1.9M |
| TWO SIGMA INVESTMENTS, LP | 395,637 | $1.5M |
| AQR CAPITAL MANAGEMENT LLC | 72,408 | $271,530 |
Source: SEC EDGAR filings · CIK 0001557746 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.